Colorectal Neoplasia in the Setting of Inflammatory Bowel Disease.
Surg Clin North Am
; 104(3): 673-684, 2024 Jun.
Article
em En
| MEDLINE
| ID: mdl-38677829
ABSTRACT
Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (colorectal adenocarcinoma [CRC]) compared with the general population. IBD-related CRC is related to poorer outcomes than non-IBD-related CRC, and it accounts for 10% to 15% of death in patients with IBD. As such, screening guidelines have been made specific to this population recommending shorter intervals of endoscopic screening to detect dysplasia and CRC relative to the general population. Advances in endoscopic technology allow for improved visualization of dysplasia, which has led to widespread adoption of dye-spray chromoendoscopy with targeted biopsy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Colorretais
/
Doenças Inflamatórias Intestinais
/
Colonoscopia
Limite:
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article